Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid

por Fenn, J, Ridgley, L A, White, A, Sarfas, C, Dennis, M, Dalgleish, A, Reljic, R, Sharpe, S, Bodman-Smith, M
Publicado 2022

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques

por White, A. D., Sarfas, C., West, K., Sibley, L. S., Wareham, A. S., Clark, S., Dennis, M. J., Williams, A., Marsh, P. D., Sharpe, S. A.
Publicado 2015

Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effec...

por Sharpe, S., White, A., Sarfas, C., Sibley, L., Gleeson, F., McIntyre, A., Basaraba, R., Clark, S., Hall, G., Rayner, E., Williams, A., Marsh, P.D., Dennis, M.
Publicado 2016

Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic

por Tipton, T. R. W., Hall, Y., Bore, J. A., White, A., Sibley, L. S., Sarfas, C., Yuki, Y., Martin, M., Longet, S., Mellors, J., Ewer, K., Günther, S., Carrington, M., Kondé, M. K., Carroll, M. W.
Publicado 2021